Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals Inc is a United States-based clinical-stage biopharmaceutical company focused on developing innovative therapies. Its primary aim is to treat cancer and other serious diseases by activating and harnessing the body’s immune system. The company advances its pipeline through rigorous research and clinical trials. Addressing challenges in the healthcare sector, specifically biotechnology, Corvus Pharmaceuticals Inc concentrates on targeted immunotherapies. Its work seeks to deliver new treatment options for patients by applying novel scientific approaches to disease management. Monitor the CRVS share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.